Evidence map›Paper›PMID 29477294›Full record

ArticleInternational journal of radiation oncology, biology, physics2018

Sensitization of Hypoxic Tumors to Radiation Therapy Using Ultrasound-Sensitive Oxygen Microbubbles.

John R Eisenbrey, Rawan Shraim, Ji-Bin Liu, Jingzhi Li, Maria Stanczak, Brian Oeffinger, Dennis B Leeper, Scott W Keith, Lauren J Jablonowski, Flemming Forsberg and 2 more

Abstract read
In one paragraph

Article in International journal of radiation oncology, biology, physics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 106 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

John R EisenbreyDepartment of Radiology, Thomas Jefferson University, Philadelphia, Pennsylvania. Electronic address: John.eisenbrey@jefferson.edu.
Rawan ShraimSchool of Biomedical Engineering and Health Sciences, Drexel University, Philadelphia, Pennsylvania.
Ji-Bin LiuDepartment of Radiology, Thomas Jefferson University, Philadelphia, Pennsylvania.
Jingzhi LiDepartment of Radiology, Thomas Jefferson University, Philadelphia, Pennsylvania; Department of Vascular Ultrasonography, Xuanwu Hospital, Capital Medical University, Beijing, China.
Maria StanczakDepartment of Radiology, Thomas Jefferson University, Philadelphia, Pennsylvania.
Brian OeffingerSchool of Biomedical Engineering and Health Sciences, Drexel University, Philadelphia, Pennsylvania.
Dennis B LeeperDepartment of Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania.
Scott W KeithDivision of Biostatistics, Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania.
Lauren J JablonowskiDepartment of Radiology, Thomas Jefferson University, Philadelphia, Pennsylvania.
Flemming ForsbergDepartment of Radiology, Thomas Jefferson University, Philadelphia, Pennsylvania.
Patrick O'KaneDepartment of Radiology, Thomas Jefferson University, Philadelphia, Pennsylvania.
Margaret A WheatleySchool of Biomedical Engineering and Health Sciences, Drexel University, Philadelphia, Pennsylvania.
Thomas Jefferson University · USDrexel University · USCapital Medical University · CN

Funding

Vevo 2100 ultrasound scannerS10OD010408 · OD · THOMAS JEFFERSON UNIVERSITY · PI FORSBERG, FLEMMING · 2012 to 2012
$525k
Oxygen Microbubbles for Overcoming Hypoxic Tumor Resistance to RadiotherapyR21CA190926 · NCI · THOMAS JEFFERSON UNIVERSITY · PI EISENBREY, JOHN, O'KANE, PATRICK · 2015 to 2016
$387k
NCI NIH HHS R21 CA190926NIH HHS S10 OD010408
6 · The paper itself

Abstract

purposeMuch of the volume of solid tumors typically exists in a chronically hypoxic microenvironment that has been shown to result in both chemotherapy and radiation therapy resistance. The purpose of this study was to use localized microbubble delivery to overcome hypoxia prior to therapy. MATERIALS AND

methodsIn this study, surfactant-shelled oxygen microbubbles were fabricated and injected intravenously to locally elevate tumor oxygen levels when triggered by noninvasive ultrasound in mice with human breast cancer tumors. Changes in oxygen and sensitivity to radiation therapy were then measured.

resultsIn this work, we show that oxygen-filled microbubbles successfully and consistently increase breast tumor oxygenation levels in a murine model by 20 mmHg, significantly more than control injections of saline solution or untriggered oxygen microbubbles (P < .001). Using photoacoustic imaging, we also show that oxygen delivery is independent of hemoglobin transport, enabling oxygen delivery to avascular regions of the tumor. Finally, we show that overcoming hypoxia by this method immediately prior to radiation therapy nearly triples radiosensitivity. This improvement in radiosensitivity results in roughly 30 days of improved tumor control, providing statistically significant improvements in tumor growth and animal survival (P < .03).

conclusionsOur findings demonstrate the potential advantages of ultrasound-triggered oxygen delivery to solid tumors and warrant future efforts into clinical translation of the microbubble platform.

Indexed as

MicrobubblesRadiation ToleranceAnimalsCell Line, TumorFemaleHumansInjections, IntravenousMiceMice, NudeOxygenOxygen ConsumptionPartial PressureRandom AllocationTriple Negative Breast NeoplasmsTumor HypoxiaTumor MicroenvironmentOxygen

Identifiers

PMID29477294
PMCPMC5886808
OpenAlexW2792817321

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.